Table 3.
OR (95% CI)
|
||
---|---|---|
<12 risk alleles | ≥12 risk alleles | |
Advanced-stage prostate cancer | ||
Overall | 1.00 (ref.) | 2.04 (1.67–2.49) |
Selenium supplement | ||
Nonuser | 1.00 (ref.) | 2.06 (1.67–2.55) |
User | 1.43 (0.70–2.96) | 0.99 (0.38–2.58) |
Pinteraction = 0.031 | ||
Nonadvanced-stage prostate cancer | ||
Overall | 1.00 (ref.) | 1.91 (1.54–2.36) |
Aspirin | ||
Nonuser | 1.00 (ref.) | 2.25 (1.69–3.00) |
User | 1.10 (0.80–1.51) | 1.70 (1.25–2.32) |
Pinteraction = 0.009 | ||
Ibuprofen | ||
Nonuser | 1.00 (ref.) | 1.99 (1.58–2.52) |
User | 1.10 (0.71–1.68) | 1.62 (1.07–2.45) |
Pinteraction = 0.023 | ||
Vegetable intake | ||
Tertile 1 | 1.00 (ref.) | 2.24 (1.54–3.25) |
Tertile 2 | 1.05 (0.71–1.56) | 1.76 (1.20–2.58) |
Tertile 3 | 0.95 (0.64–1.42) | 1.71 (1.16–2.52) |
Pinteraction = 0.010 |
NOTE: Results are shown when Pinteraction < 0.05 (Supplementary Table S2).